ARCHIVES

Intarferon Results Promising, ACS Says, And commits Another $3.4 Million

This article is from The Cancer Letter archive.

Vol. 06 No. 08 | February 22, 1980

Download PDF Visit The Full Archive

Related Articles

Interview with Christine Berg: ST Findings Relevant Only To High-Risk;

November 26, 2010

Clinical Trial System Inefficient, UPCI Director Tells Senate

June 7, 2002

Hollings Resolution Recognizes 20th Year Of National Cancer Act

May 3, 1991

PV-10 Produces 51 Percent Response Rate in Phase II Trial

October 26, 2012

Report Redefines Cancer Control Research, Sets the Agenda For Newest NCI Division

October 17, 1997

In Brief: Subcommittee Okays $980 Million for NCI In 1983, House Passes Waxman Bill, With Centers Line Item

October 8, 1982